Head: Treatment Research in HIV and TB, Centre for the AIDS Program of Research in South Africa (CAPRISA)
Dr Kogieleum Naidoo, MBCHB, PhD, is the clinical head of the HIV and TB Treatment Research Program at the Centre of the AIDS Programme of Research in South Africa (CAPRISA), and Honorary Associate Professor in the College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Her contribution to HIV and TB treatment spans over two decades. Dr Naidoo was lead PI on several CAPRISA studies that have shaped both local and international guidelines on TB-HIV treatment integration. She has been a lead investigator in several Phase II and III TB-HIV and drug resistant-TB treatment trials. These include several international, multicentred, multi-country collaborative clinical trials.
She has supervised post-doctoral, doctoral, and masters’ candidates, authored peer reviewed publications, and co-authored chapters in several global health books. She is the editor of the Casebook, Radiological Features of TB in HIV Co-infected Patients. In 2013, she received the Union Scientific Prize for her scientific contributions in TB awarded by the International Union against Tuberculosis and Lung Disease.
Jul 21, 2020 14:02 pm UTC| Health
When the COVID-19 pandemic began to spread rapidly across the globe, scientists expressed concern that people living with HIV would be particularly severely affected. This was because those with compromised immune systems...